Compare BSX & RCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | RCL |
|---|---|---|
| Founded | 1979 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4B | 74.9B |
| IPO Year | 2010 | 1997 |
| Metric | BSX | RCL |
|---|---|---|
| Price | $63.82 | $281.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 18 |
| Target Price | $102.19 | ★ $356.94 |
| AVG Volume (30 Days) | ★ 14.3M | 2.1M |
| Earning Date | 04-22-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | ★ 55.20 | 42.69 |
| EPS | 1.94 | ★ 15.61 |
| Revenue | ★ $9,076,000,000.00 | $8,777,845,000.00 |
| Revenue This Year | $11.91 | $11.26 |
| Revenue Next Year | $10.26 | $7.32 |
| P/E Ratio | $32.46 | ★ $18.07 |
| Revenue Growth | ★ 12.49 | N/A |
| 52 Week Low | $60.59 | $185.50 |
| 52 Week High | $109.50 | $366.50 |
| Indicator | BSX | RCL |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 51.16 |
| Support Level | N/A | $276.37 |
| Resistance Level | $76.77 | $309.18 |
| Average True Range (ATR) | 1.78 | 10.91 |
| MACD | 0.24 | 2.37 |
| Stochastic Oscillator | 30.40 | 48.34 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Royal Caribbean is the world's second-largest cruise company by revenues, operating 69 ships across five global and partner brands in the cruise vacation industry. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises. The selection of brands in the portfolio allows Royal to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in 2021, plans to launch its new Celebrity River Cruise brand in 2027, and is set to operate eight private destination locations by 2028 (up from three currently).